Matches in SemOpenAlex for { <https://semopenalex.org/work/W11097077> ?p ?o ?g. }
- W11097077 endingPage "752" @default.
- W11097077 startingPage "747" @default.
- W11097077 abstract "To evaluate the usefulness of serum prostate specific antigen in the preoperative staging of prostate cancer we examined tumor volume and differentiation, as well as benign prostatic hyperplasia volume to determine their influence on serum antigen levels. Serum prostate specific antigen was measured in 350 men with clinically localized prostate cancer and preoperatively in 72 men with documented benign prostatic hyperplasia. Although the mean antigen levels increased with advancing pathological stage, the usefulness of prostate specific antigen to predict pathological stage for an individual patient was limited: 1 of 102 men (0.9%) with prostate specific antigen levels of less than 2.8 ng./ml. had positive lymph nodes and 5 of 5 men with levels of greater than 100 ng./ml. had either seminal vesicle or lymph node involvement. However, for the majority of men (greater than 70%) with prostate specific antigen values between these 2 extremes the antigen levels did not accurately predict pathological stage. Because serum prostate specific antigen levels correlated with morphometrically determined tumor volume (r equals 0.535, p less than 0.01) they should, in fact, be predictive of pathological stage. However, most men with prostate cancer also have varying degrees of benign prostatic hyperplasia tissue in the gland producing prostate specific antigen. We have found that serum prostate specific antigen does not correlate with the volume of benign hyperplasia within the gland (r equals 0.21, p greater than 0.05). In addition, immunohistochemical studies have suggested that the lack of correlation between pathological stage and serum prostate specific antigen might be explained by a decrease in the production of antigen with increasing histological grade. Our findings of a negative correlation (r equals -0.37, p less than 0.01) between serum prostate specific antigen levels and Gleason score adjusted for tumor volume confirmed this suggestion. Consequently, serum prostate specific antigen levels do not reflect tumor burden and pathological stage accurately in individual patients for 2 reasons: 1) the unpredictable contribution from the benign prostatic hyperplasia component of the gland and 2) the decreasing production of prostate specific antigen by higher grade lesions as tumor volume increases." @default.
- W11097077 created "2016-06-24" @default.
- W11097077 creator A5041679447 @default.
- W11097077 creator A5041961633 @default.
- W11097077 creator A5062227791 @default.
- W11097077 creator A5063449536 @default.
- W11097077 creator A5075913396 @default.
- W11097077 creator A5078939311 @default.
- W11097077 creator A5085656561 @default.
- W11097077 creator A5086869741 @default.
- W11097077 date "1990-04-01" @default.
- W11097077 modified "2023-10-10" @default.
- W11097077 title "Prostate Specific Antigen in the Staging of Localized Prostate Cancer: Influence of Tumor Differentiation, Tumor Volume and Benign Hyperplasia" @default.
- W11097077 cites W116956788 @default.
- W11097077 cites W1945252083 @default.
- W11097077 cites W2002538042 @default.
- W11097077 cites W2048750477 @default.
- W11097077 cites W2108144370 @default.
- W11097077 cites W2330292521 @default.
- W11097077 cites W2408116045 @default.
- W11097077 cites W2411174434 @default.
- W11097077 cites W2411527553 @default.
- W11097077 cites W2418785680 @default.
- W11097077 cites W38427941 @default.
- W11097077 cites W53877061 @default.
- W11097077 doi "https://doi.org/10.1016/s0022-5347(17)40079-6" @default.
- W11097077 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1690309" @default.
- W11097077 hasPublicationYear "1990" @default.
- W11097077 type Work @default.
- W11097077 sameAs 11097077 @default.
- W11097077 citedByCount "577" @default.
- W11097077 countsByYear W110970772012 @default.
- W11097077 countsByYear W110970772013 @default.
- W11097077 countsByYear W110970772014 @default.
- W11097077 countsByYear W110970772015 @default.
- W11097077 countsByYear W110970772016 @default.
- W11097077 countsByYear W110970772017 @default.
- W11097077 countsByYear W110970772018 @default.
- W11097077 countsByYear W110970772019 @default.
- W11097077 countsByYear W110970772020 @default.
- W11097077 countsByYear W110970772022 @default.
- W11097077 countsByYear W110970772023 @default.
- W11097077 crossrefType "journal-article" @default.
- W11097077 hasAuthorship W11097077A5041679447 @default.
- W11097077 hasAuthorship W11097077A5041961633 @default.
- W11097077 hasAuthorship W11097077A5062227791 @default.
- W11097077 hasAuthorship W11097077A5063449536 @default.
- W11097077 hasAuthorship W11097077A5075913396 @default.
- W11097077 hasAuthorship W11097077A5078939311 @default.
- W11097077 hasAuthorship W11097077A5085656561 @default.
- W11097077 hasAuthorship W11097077A5086869741 @default.
- W11097077 hasConcept C121608353 @default.
- W11097077 hasConcept C126322002 @default.
- W11097077 hasConcept C126894567 @default.
- W11097077 hasConcept C142724271 @default.
- W11097077 hasConcept C143998085 @default.
- W11097077 hasConcept C146357865 @default.
- W11097077 hasConcept C147483822 @default.
- W11097077 hasConcept C151730666 @default.
- W11097077 hasConcept C203014093 @default.
- W11097077 hasConcept C207886595 @default.
- W11097077 hasConcept C2776235491 @default.
- W11097077 hasConcept C2777562237 @default.
- W11097077 hasConcept C2780192828 @default.
- W11097077 hasConcept C2780849966 @default.
- W11097077 hasConcept C2781406297 @default.
- W11097077 hasConcept C71924100 @default.
- W11097077 hasConcept C86803240 @default.
- W11097077 hasConcept C87874733 @default.
- W11097077 hasConceptScore W11097077C121608353 @default.
- W11097077 hasConceptScore W11097077C126322002 @default.
- W11097077 hasConceptScore W11097077C126894567 @default.
- W11097077 hasConceptScore W11097077C142724271 @default.
- W11097077 hasConceptScore W11097077C143998085 @default.
- W11097077 hasConceptScore W11097077C146357865 @default.
- W11097077 hasConceptScore W11097077C147483822 @default.
- W11097077 hasConceptScore W11097077C151730666 @default.
- W11097077 hasConceptScore W11097077C203014093 @default.
- W11097077 hasConceptScore W11097077C207886595 @default.
- W11097077 hasConceptScore W11097077C2776235491 @default.
- W11097077 hasConceptScore W11097077C2777562237 @default.
- W11097077 hasConceptScore W11097077C2780192828 @default.
- W11097077 hasConceptScore W11097077C2780849966 @default.
- W11097077 hasConceptScore W11097077C2781406297 @default.
- W11097077 hasConceptScore W11097077C71924100 @default.
- W11097077 hasConceptScore W11097077C86803240 @default.
- W11097077 hasConceptScore W11097077C87874733 @default.
- W11097077 hasIssue "4" @default.
- W11097077 hasLocation W110970771 @default.
- W11097077 hasLocation W110970772 @default.
- W11097077 hasOpenAccess W11097077 @default.
- W11097077 hasPrimaryLocation W110970771 @default.
- W11097077 hasRelatedWork W2353798281 @default.
- W11097077 hasRelatedWork W2354209970 @default.
- W11097077 hasRelatedWork W2371422341 @default.
- W11097077 hasRelatedWork W2377899455 @default.
- W11097077 hasRelatedWork W2389718753 @default.
- W11097077 hasRelatedWork W2400783631 @default.